Back
Vanguard Total Stock Market Index Fund ETF Vs. Rigel Pharmaceuticals, Inc. Industry Stock Comparison
Buy
64
VTI
Vanguard Total Stock Market Index Fund ETF
Last Price:
$336.26
Seasonality Move:
1.06%
Buy
72
RIGL
Rigel Pharmaceuticals, Inc.
Last Price:
$41.63
Seasonality Move:
-1.35%
Buy
64
Vanguard Total Stock Market Index Fund ETF (VTI)
is a Buy
Is Vanguard Total Stock Market Index Fund ETF a Buy, Sell or Hold?
-
The current Vanguard Total Stock Market Index Fund ETF [VTI] share price is $333.25. The Score for VTI is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
-
VTI is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
72
Rigel Pharmaceuticals, Inc. (RIGL)
is a Buy
Is Rigel Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Rigel Pharmaceuticals, Inc. [RIGL] share price is $41.77. The Score for RIGL is 72, which is 44% above its historic median score of 50, and infers lower risk than normal.
-
RIGL is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
VTI Stock Price Chart
What is Vanguard Total Stock Market Index Fund ETF's stock price today?
-
The Vanguard Total Stock Market Index Fund ETF share price today is $333.25Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VTI is experiencing buying pressure, which is a positive indicator for future bullish movement.
RIGL Stock Price Chart
What is Rigel Pharmaceuticals, Inc.'s stock price today?
-
The Rigel Pharmaceuticals, Inc. share price today is $41.77Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RIGL is experiencing selling pressure, which indicates risk of future bearish movement.
VTI Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 46.95 | Buy |
| Relative Strength Index (14 RSI): | 49.25 | Sell |
| Chaikin Money Flow: | -1534377 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
RIGL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 5.92 | Buy |
| Relative Strength Index (14 RSI): | 48.84 | Sell |
| Chaikin Money Flow: | -387889 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
VTI Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 335.56 | Sell |
| 20-day SMA: | 333.87 | Sell |
| 50-day SMA: | 332.11 | Buy |
| 200-day SMA: | 306.08 | Buy |
| 8-day EMA: | 131.22 | Buy |
| 20-day EMA: | 60.23 | Buy |
| 50-day EMA: | 25.53 | Buy |
| 200-day EMA: | 6.57 | Buy |
RIGL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 41.82 | Sell |
| 20-day SMA: | 45.2 | Sell |
| 50-day SMA: | 37.87 | Buy |
| 200-day SMA: | 27.55 | Buy |
| 8-day EMA: | 16.53 | Buy |
| 20-day EMA: | 7.59 | Buy |
| 50-day EMA: | 3.22 | Buy |
| 200-day EMA: | 0.83 | Buy |
Vanguard Total Stock Market Index Fund ETF Earnings Growth & VTI Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Rigel Pharmaceuticals, Inc. Earnings Growth & RIGL Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.35 per share, a decrease next quarter of $0.00 per share, an increase this year of $6.13 per share, and a decrease next year of $2.31 per share.
Vanguard Total Stock Market Index Fund ETF Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Rigel Pharmaceuticals, Inc. Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||